Researchers from Murcia use artificial intelligence to find two plant compounds similar to new anti-obesity drugs. The results will be presented at the European scientific event that addresses the latest developments in obesity (ECO 2024), in May.
Semaglutide and tirzepatide, better known to ordinary people as 'ozempic','saxenda', 'wegoby' and company, are glucagon-like peptide 1 (GLP-1) receptor agonists.